Immunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation

Yun,Xia; Wang,Lihong; Cao,Lei; Okada,Norihiko; Miki,Yoshio

doi:10.3892/ol_00000077

Immunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation

Authors:
- Xia Yun
- Lihong Wang
- Lei Cao
- Norihiko Okada
- Yoshio Miki
View Affiliations

Affiliations: Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
Published online on: May 1, 2010 https://doi.org/10.3892/ol_00000077
Pages: 437-443

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

β-catenin plays an important role in the maintenance of cell adhesion and is a key component of the Wnt signaling pathway. However, little is known about its prognostic significance or its role in tumor progression in tongue squamous cell carcinoma (SCC). This study conducted an immunohistochemical analysis of the expression of β-catenin. Moreover, its possible correlation with clinical parameters and with the expression of the functionally related molecular markers cyclin D1 and p53 was evaluated in 50 cases of tongue SCC and 10 cases of normal tongue epithelium. The ki-67 labeling index (LI) was also examined to evaluate cellular proliferation. Our results showed a higher frequency of abnormal β-catenin expression, positive cyclin D1 and p53 expression, and a significantly higher ki-67 LI in the tongue SCC samples compared with normal tongue epithelium (P<0.05). Abnormal β-catenin and a higher ki-67 expression was significantly associated with moderately or poorly differentiated carcinoma (P<0.05). Cyclin D1-positive immunostaining showed a statistically significant association with lymph node metastasis (P<0.05). Furthermore, the abnormal expression of β-catenin significantly correlated with a higher ki-67 LI and p53 expression (P<0.05); however, there was no correlation with cyclin D1 expression (P>0.05). Taken together, our results suggest that abnormal β-catenin expression is related to the impaired cellular differentiation and proliferation involved in tumor progression in tongue SCC.

View Figures

View References

1	Ozawa M, Baribault H and Kemler R: The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8:1711–1717. 1989.
2	Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
3	Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 84:345–357. 1996. View Article : Google Scholar : PubMed/NCBI
4	Miller JR and Moon RT: Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev. 10:2527–2539. 1996. View Article : Google Scholar : PubMed/NCBI
5	Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R and Ben-Ze’ev A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 96:5522–5527. 1999. View Article : Google Scholar : PubMed/NCBI
6	He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
7	Brabletz T, Jung A, Dag S, Hlubek F and Kirchner T: beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 155:1033–1038. 1999. View Article : Google Scholar : PubMed/NCBI
8	Aberle H, Bauer A, Stappert J, Kispert A and Kemler R: beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
9	Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 382:638–642. 1996. View Article : Google Scholar : PubMed/NCBI
10	Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422–426. 1999. View Article : Google Scholar : PubMed/NCBI
11	Lin SY, Xia W, Wang JC, et al: Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA. 97:4262–4266. 2000. View Article : Google Scholar : PubMed/NCBI
12	Qiao Q, Ramadani M, Gansauge S, Gansauge F, Leder G and Beger HG: Reduced membranous and ectopic cytoplasmic expression of beta-catenin correlates with cyclin D1 overexpression and poor prognosis in pancreatic cancer. Int J Cancer. 95:194–197. 2001. View Article : Google Scholar : PubMed/NCBI
13	Damalas A, Ben-Ze’ev A, Simcha I, et al: Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 18:3054–3063. 1999. View Article : Google Scholar : PubMed/NCBI
14	Damalas A, Kahan S, Shtutman M, Ben-Ze’ev A and Oren M: Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20:4912–4922. 2001. View Article : Google Scholar : PubMed/NCBI
15	Matsuzawa SI and Reed JC: Siah-1, SIP and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell. 7:915–926. 2001. View Article : Google Scholar : PubMed/NCBI
16	Liu J, Stevens J, Rote CA, et al: Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell. 7:927–936. 2001. View Article : Google Scholar : PubMed/NCBI
17	Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y and Hirohashi S: Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology. 59:302–309. 2000. View Article : Google Scholar : PubMed/NCBI
18	Karayiannakis AJ, Nakopoulou L, Gakiopoulou H, Keramopoulos A, Davaris PS and Pignatelli M: Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur J Surg Oncol. 27:31–36. 2001. View Article : Google Scholar : PubMed/NCBI
19	Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M and Farthing MJ: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology. 112:46–54. 1997. View Article : Google Scholar : PubMed/NCBI
20	Papadavid E, Pignatelli M, Zakynthinos S, Krausz T and Chu AC: Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta- and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol. 196:154–162. 2002. View Article : Google Scholar : PubMed/NCBI
21	Endo K, Ueda T, Ueyama J, Ohta T and Terada T: Immunoreactive E-cadherin, alpha-catenin, beta-catenin and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters and patients’ survival. Hum Pathol. 31:558–565. 2000.PubMed/NCBI
22	Pindborg JJ, Reichart PA, Smith CJ and van der Waal I: World Health Organisation International Histological Classification of Tumours. Histological Typing of Cancer and Precancer of the Oral Mucosa (2nd edition). Springer. (Berlin). 1997. View Article : Google Scholar
23	Lo Muzio L, Staibano S, Pannone G, et al: Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res. 19:3817–3826. 1999.
24	Ho CM, Lam KH, Wei WI, Lau SK and Lam LK: Occult lymph node metastasis in small oral tongue cancers. Head Neck. 14:359–363. 1992. View Article : Google Scholar : PubMed/NCBI
25	Johnson JT, Barnes EL, Myers EN, Schramm VL Jr, Borochovitz D and Sigler BA: The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol. 107:725–729. 1981. View Article : Google Scholar : PubMed/NCBI
26	Yamazaki H, Inoue T, Yoshida K, et al: Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiat Oncol Biol Phys. 58:139–146. 2004. View Article : Google Scholar : PubMed/NCBI
27	Odajima T, Sasaki Y, Tanaka N, et al: Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol. 36:234–241. 2005. View Article : Google Scholar : PubMed/NCBI
28	Ueda G, Sunakawa H, Nakamori K, et al: Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 35:356–361. 2006. View Article : Google Scholar : PubMed/NCBI
29	Wang L, Liu T, Nishioka M, Aguirre RL, Win SS and Okada N: Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol. 42:625–631. 2006. View Article : Google Scholar : PubMed/NCBI
30	Chen TM and Defendi V: Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene. 7:1541–1547. 1992.PubMed/NCBI
31	Horak E, Smith K, Bromley L, LeJeune S, Greenall M, Lane D and Harris AL: Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. Oncogene. 6:2277–2284. 1991.PubMed/NCBI
32	Xu J and Morris GF: p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation. Mol Cell Biol. 19:12–20. 1999.PubMed/NCBI
33	Chung GG, Zerkowski MP, Ocal IT, et al: beta-catenin and p53 analyses of a breast carcinoma tissue microarray. Cancer. 100:2084–2092. 2004. View Article : Google Scholar : PubMed/NCBI
34	Prange W, Breuhahn K, Fischer F, et al: Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol. 201:250–259. 2003. View Article : Google Scholar : PubMed/NCBI
35	Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304–6311. 1991.PubMed/NCBI
36	Polakis P: Wnt signaling and cancer. Genes Dev. 14:1837–1851. 2000.
37	Gonzalez MV, Pello MF, Ablanedo P, Suarez C, Alvarez V and Coto E: Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck. J Clin Pathol. 51:520–524. 1998. View Article : Google Scholar : PubMed/NCBI
38	Iwai S, Katagiri W, Kong C, Amekawa S, Nakazawa M and Yura Y: Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 131:773–782. 2005. View Article : Google Scholar : PubMed/NCBI